Position in NAMS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$90,639,740
-$6,750,127 QoQ
Shares Held
2,831,607
+2.0% QoQ
Ownership
2.42%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NAMS Over Time
Shares Held
Position Value (USD)
Derivatives in NAMS
reported options exposure · as of Dec 31, 2023CallValue
$10,161,818
CallShares
909,742
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Polar Capital Holdings Plc holds $3,129,351,296 across 43 Biotechnology names. NAMS ranks #13 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | XENE |
Xenon Pharmaceuticals Inc.
|
4,405,312 | $256,168,892 | |
| 2 | ELVN |
Enliven Therapeutics, Inc.
|
5,065,933 | $198,584,573 | |
| 3 | NUVL |
Nuvalent, Inc.
|
1,831,253 | $187,611,869 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
2,519,306 | $187,083,663 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
289,310 | $151,445,105 | |
| 6 | ASND |
Ascendis Pharma A/S
|
651,712 | $149,066,085 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
192,546 | $148,768,741 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,615,586 | $140,507,514 |
All Filings in NAMS
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $90,639,740 | 2,831,607 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $97,389,867 | 2,776,222 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $82,806,870 | 2,911,634 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $45,596,977 | 2,517,779 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $46,057,500 | 2,250,000 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $44,975,000 | 1,750,000 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $24,983,000 | 1,505,000 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $19,259,677 | 1,002,586 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $29,623,658 | 1,252,586 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $10,161,818 | 909,742 | Call | Defined | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||